Skip to search formSkip to main content

Neoplastic Post-Transplant Lymphoproliferative Disorder

Known as: Neoplastic PTLD, Post-Transplant Lymphoproliferative Neoplasm, Post-Transplant Lymphocytic Neoplasm 
A lymphoproliferative disorder arising as a result of post-transplant immunosuppression therapy. It is characterized by the presence of tissue… Expand
National Institutes of Health

Related topics

Related topics

10 relations
Atypical lymphocyteHematopoietic and Lymphoid CellHematopoietic and Lymphoid TissueImmunologic Deficiency Syndromes
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Diagnosis and treatment of neoplastic post-transplant lymphoproliferative disorder following hematopoietic stem cell transplant in β-thalassemia
Introduction: Post-transplant lymphoproliferative disorder (PTLD) is the most common form of lymphoproliferation in childhood and… Expand
  • figure 1
  • figure 2
Is this relevant?
2016
2016
Epstein-Barr virus load in transplant patients: Early detection of post-transplant lymphoproliferative disorders.
High levels of circulating EBV load are used as a marker of post-transplant lymphoproliferative disorders (PTLD). There is no… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE